Profile
Sector:
HealthcareCountry:
United StatesIPO:
20 September 2018Website:
http://www.elanco.comNext earnings report:
07 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:22:52 GMTDividend
Analysts recommendations
Institutional Ownership
ELAN Latest News
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated.
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated.
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated.
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE: ELAN) concerning possible violations of federal securities laws.
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) on behalf of Elanco stockholders. Our investigation concerns whether Elanco has violated the federal securities laws and/or engaged in other unlawful business practices.
What type of business is Elanco Animal Health Incorporated?
Elanco Animal Health Incorporated is a pharmaceutical company that develops and markets products for the treatment of animals. The Prevention of diseases in domestic animals segment includes a wide range of parasiticides. The Therapy for domestic animals segment provides means and services for pain and osteoarthritis treatment, with different modes of action, indications, and disease stages. The Protein and Health segment includes vaccines, food enzymes, and antibiotics for animals. The Ruminant and Swine category segment is engaged in the development of vaccines, antibiotics, implants, parasiticides, and animal origin products widely used in the breeding of ruminant animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
What sector is Elanco Animal Health Incorporated in?
Elanco Animal Health Incorporated is in the Healthcare sector
What industry is Elanco Animal Health Incorporated in?
Elanco Animal Health Incorporated is in the Drug Manufacturers - Specialty & Generic industry
What country is Elanco Animal Health Incorporated from?
Elanco Animal Health Incorporated is headquartered in United States
When did Elanco Animal Health Incorporated go public?
Elanco Animal Health Incorporated initial public offering (IPO) was on 20 September 2018
What is Elanco Animal Health Incorporated website?
https://www.elanco.com
Is Elanco Animal Health Incorporated in the S&P 500?
No, Elanco Animal Health Incorporated is not included in the S&P 500 index
Is Elanco Animal Health Incorporated in the NASDAQ 100?
No, Elanco Animal Health Incorporated is not included in the NASDAQ 100 index
Is Elanco Animal Health Incorporated in the Dow Jones?
No, Elanco Animal Health Incorporated is not included in the Dow Jones index
When does Elanco Animal Health Incorporated report earnings?
The next expected earnings date for Elanco Animal Health Incorporated is 07 August 2024